With regard to mechanism of action, the bulk of evidence indicates that MEG3 acts as a tumor suppressor through the accumulation of p53 protein and successive activation of its downstream target genes [13]; this mechanism, however, cannot be relevant in the context of HGSOC, characterized by mutation in the TP53 gene [29]. This evidence concerns the gene TP53 and neoplasm.